North America E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging); End User (Commercial or Private Labs, Physician Offices, Hospitals, Public Health Labs, and Academic Research Institutes), and Country
Market Introduction
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria. These bacteria are the leading cause of diarrheal diseases, especially among children primarily through food or drinking water contaminated with animal or human feces. Some strains of the E. coli bacteria produce Shiga toxin that causes gastrointestinal (GI) infections and medical complications like gastrointestinal tract infections, cholangitis, cholecystitis, bacteremia, neonatal meningitis and pneumonia, urinary tract infection (UTI). This syndrome, if untreated, can result in harmful results such as kidney failure. E. coli tests are used to diagnose GI infections using stool samples. These tests can be performed using molecular diagnostic kits and immunoassays.
Get more information on this report : 
Market Overview and Dynamics
The North AmericaE. colitestingmarket is to reach US$ 1,165.0 Mn by 2027 from US$ 680.9 Mn in 2019. The market is anticipated to grow at a CAGR of 7.1% during 2019–2027.Factors such as the rise in E. coli testing, growing product innovation, and rising research activities are expected to boost the growth of the E. colitesting market. However, the market is likely to get impacted by the risk factor such as testing challenges during the forecast period.
Key Market Segments
In terms of technology, the monoclonal antibodies segment accounted for the largest share of the North America E. colitestingmarket in 2019. The public health labs segment accounted for the largest share of the North America E. colitestingmarket, by end-user, in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America E. colitestingmarket report are theWorld Health Organization (WHO), Centers of Disease Control and Prevention (CDC),OECD Health Statistics, andothers.
Reasons to buy report
- It provides understanding of the North America, E. coli testingmarket landscape and identifies E. colitestingmarket segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America E. coli testingmarket.
- It helps efficiently plan merger and acquisition, and partnership deals in the E. colitestingmarket by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofE. colitestingmarket performance of various segments pertaining to the North America E. coli testingmarket.
- It providesE. colitestingmarket revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA E. COLITESTINGMARKET SEGMENTATION
By Technology
- Monoclonal Antibodies
- Differential Light Scattering
- Molecular Diagnostics
- Immunoassays
- Chromatography
- Flow Cytometry
- Gel Microdroplets
- Diagnostic Imaging
By End-User
- Commercial or Private Labs
- Physician Offices
- Hospitals
- Public Health Labs
- Academic Research Institutes
By Country
- US
- Canada
- Mexico
Company Profiles
- Bio-Rad Laboratories, Inc
- Pro-Lab Diagnostics, Inc.
- Abbott (Alere Inc.)
- IDEXX Laboratories, Inc.
- Meridian Bioscience, Inc.
- BD
- Thermo Fisher Scientific, Inc.
- NEOGEN Corporation
- Hologic, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America E. coli Testing Market – By Technology
1.3.2 North America E. coli Testing Market – By End-User
1.3.3 North America E. coli Testing Market – By Country
2. North America E. coli Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America E. coli Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 E. coli Testing Market - North America PEST Analysis
4.3 Expert Opinion
5. North America E. coli Testing Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing E. coli Testing
5.1.2 Growing Product Innovations
5.1.3 Rising Research Activities
5.2 Key Market Restraints
5.2.1 Testing Challenges
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Multiplex PCR Technology
5.4 Future Trends
5.4.1 Developments in Biotechnology
5.5 Impact Analysis
6. E. coli Testing Market – North America Analysis
6.1 North America E. coli Testing Market Revenue Forecasts and Analysis
7. North America E. coli Testing Market Analysis – By Technology
7.1 Overview
7.2 North America E. coli Testing Market, By Technology 2019-2027 (%)
7.2.1 North America E. coli testing Market Devices Revenue and Forecasts to 2027, By Technology (US$ Mn)
7.3 Monoclonal Antibodies
7.3.1 Overview
7.3.2 North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Differential Light Scattering
7.4.1 Overview
7.4.2 North America Differential Light Scattering Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 North America Molecular Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Immunoassays
7.6.1 Overview
7.6.2 North America Immunoassays Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Chromatography
7.7.1 Overview
7.7.2 North America Chromatography Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Flow Cytometry
7.8.1 Overview
7.8.2 North America Flow Cytometry Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Gel Microdroplets
7.9.1 Overview
7.9.2 North America Gel Microdroplets Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Diagnostic Imaging
7.10.1 Overview
7.10.2 North America Diagnostic Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America E. coli Testing Market Analysis – By End-User
8.1 Overview
8.2 North America E. coli Testing Market, By Application 2019-2027 (%)
8.2.1 North America E. coli Testing Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
8.3 Commercial or Private Labs
8.3.1 Overview
8.3.2 North America Commercial or Private Labs Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Physician Offices
8.4.1 Overview
8.4.2 North America Physician Offices Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Hospitals
8.5.1 Overview
8.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Public Health Labs
8.6.1 Overview
8.6.2 North America Public Health Labs Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Academic Research Institutes
8.7.1 Overview
8.7.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9. E. coli Testing Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 North America E. coli Testing Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: E. coli Testing Market, by Technology, 2018–2027 (USD Million)
9.1.4 North America: E. coli Testing Market, by End User , 2018–2027 (USD Million)
9.1.5 North America: E. coli Testing Market, by Country, 2019 & 2027 (%)
9.1.6 US: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: E. coli Testing Market, by Technology, 2018–2027 (USD Million)
9.1.6.3 US: E. coli Testing Market, by End User , 2018–2027 (USD Million)
9.1.7 Canada: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: E. coli Testing Market, by Technology, 2018–2027 (USD Million)
9.1.7.3 Canada: E. coli Testing Market, by End User , 2018–2027 (USD Million)
9.1.8 Mexico: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: E. coli Testing Market, by Technology, 2018–2027 (USD Million)
9.1.8.3 Mexico: E. coli Testing Market, by End User , 2018–2027 (USD Million)
10. Impact Of COVID-19 Pandemic on North America E. coli Testing Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 BIO-RAD LABORATORIES INC.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Pro Lab Diagnostics Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IDEXX LABORATORIES, INC.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 MERIDIAN BIOSCIENCE, INC.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BD
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 THERMO FISHER SCIENTIFIC INC.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 NEOGEN Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Hologic, Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 Glossary of TermsLIST OF TABLES
Table 1. North America E. coli Testing Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 2. North America E. coli Testing Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 3. North America E. coli Testing Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. North America E. coli Testing Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 5. US E. coli Testing Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 6. US E. coli Testing Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. Canada E. coli Testing Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada E. coli Testing Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico E. coli Testing Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico E. coli Testing Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 11. Glossary of Terms, E. coli Testing Market
LIST OF FIGURES
Figure 1. E. coli Testing Market Segmentation
Figure 2. North America E. coli Testing Market Overview
Figure 3. Monoclonal Antibodies Segment Held Largest Share of E. coli Testing Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America E. coli Testing Market - Leading Country Markets (US$ Mn)
Figure 6. E. coli Testing Market - North America PEST Analysis
Figure 7. E. coli Testing Market Impact Analysis of Driver and Restraints
Figure 8. North America E. coli Testing market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America E. coli Testing Market, by technology 2019 & 2027 (%)
Figure 10. North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Differential Light Scattering Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Molecular Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Immunoassays Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Chromatography Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Flow Cytometry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Gel Microdroplets Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Diagnostic Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America E. coli Testing Market, by Application 2019 & 2027 (%)
Figure 19. North America Commercial or Private Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Physician Offices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Public Health Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America: E. coli Testing Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. North America E. coli Testing Market Revenue and Forecast to 2027 (USD Million)
Figure 26. North America: E. coli Testing Market, by Country, 2019 & 2027 (%)
Figure 27. US: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Canada: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Mexico: E. coli Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America E. coli Testing Market
- Bio-Rad Laboratories, Inc
- Pro-Lab Diagnostics, Inc.
- Abbott (Alere Inc.)
- IDEXX Laboratories, Inc.
- Meridian Bioscience, Inc.
- BD
- Thermo Fisher Scientific, Inc.
- NEOGEN Corporation
- Hologic, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America E. coliTesting Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America E. coli Testing Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution